All trades / HTFL
36Open-market trades
−20.7%Avg 90d after buys
−14.7%Avg 90d after sales
+24.0%Avg 180d after buys
Price and insider prints
HTFL adjusted close▲ buy▼ sale
Trades
| Date | Form 4 | Ticker | Insider | Side | Shares | Value | 90d | 180d |
|---|---|---|---|---|---|---|---|---|
| 9/18/2026 | Form 410b5-1 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | Verghese VikramChief Financial OfficerVikram Verghese has served as our Chief Financial Officer since June 2023. He joined the Company in November 2021 as Senior Vice President of Upstream Marketing, Business Development, and Strategy. Prior to that, Mr. Verghese held various positions at Medtronic from 2008 until 2021 in various leadership roles spanning global marketing, regulatory and clinical affairs and business development. After completing his undergraduate degree in Electrical and Electronic Engineering in India, Mr. Verghese received an M.S. in Biomedical Engineering from the University of Southern California and an M.B.A. from University of Pennsylvania’s The Wharton School. He is also a CFA charter holder. Campbell D.K. Rogers, M.D.… | SELL | 16,766 | $850.9K | — | — |
| 9/17/2026 | Form 410b5-1 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | Verghese VikramChief Financial OfficerVikram Verghese has served as our Chief Financial Officer since June 2023. He joined the Company in November 2021 as Senior Vice President of Upstream Marketing, Business Development, and Strategy. Prior to that, Mr. Verghese held various positions at Medtronic from 2008 until 2021 in various leadership roles spanning global marketing, regulatory and clinical affairs and business development. After completing his undergraduate degree in Electrical and Electronic Engineering in India, Mr. Verghese received an M.S. in Biomedical Engineering from the University of Southern California and an M.B.A. from University of Pennsylvania’s The Wharton School. He is also a CFA charter holder. Campbell D.K. Rogers, M.D.… | SELL | 7,579 | $379.8K | — | — |
| 9/15/2026 | Form 410b5-1 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | Verghese VikramChief Financial OfficerVikram Verghese has served as our Chief Financial Officer since June 2023. He joined the Company in November 2021 as Senior Vice President of Upstream Marketing, Business Development, and Strategy. Prior to that, Mr. Verghese held various positions at Medtronic from 2008 until 2021 in various leadership roles spanning global marketing, regulatory and clinical affairs and business development. After completing his undergraduate degree in Electrical and Electronic Engineering in India, Mr. Verghese received an M.S. in Biomedical Engineering from the University of Southern California and an M.B.A. from University of Pennsylvania’s The Wharton School. He is also a CFA charter holder. Campbell D.K. Rogers, M.D.… | SELL | 668 | $33.4K | — | — |
| 9/14/2026 | Form 410b5-1 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | Verghese VikramChief Financial OfficerVikram Verghese has served as our Chief Financial Officer since June 2023. He joined the Company in November 2021 as Senior Vice President of Upstream Marketing, Business Development, and Strategy. Prior to that, Mr. Verghese held various positions at Medtronic from 2008 until 2021 in various leadership roles spanning global marketing, regulatory and clinical affairs and business development. After completing his undergraduate degree in Electrical and Electronic Engineering in India, Mr. Verghese received an M.S. in Biomedical Engineering from the University of Southern California and an M.B.A. from University of Pennsylvania’s The Wharton School. He is also a CFA charter holder. Campbell D.K. Rogers, M.D.… | SELL | 4,593 | $230.7K | — | — |
| 9/11/2026 | Form 410b5-1 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | Farquhar John C.M.Chief Executive OfficerJohn C.M. Farquhar has served as our Chief Executive Officer and as a member of our Board since March 2022 and as our President since January 2022, and he served as our Chief Operating Officer from July 2021 to March 2022. Prior to joining the Company, from March 2008 to July 2021, Mr. Farquhar held numerous positions of increasing responsibility across the cardiovascular and diabetes portfolios of Medtronic Public Limited Company (“Medtronic”), a global medical technology company, most recently serving as President and General Manager from June 2018 until July 2021. Prior to that, Mr. Farquhar served as a Marketing Manager at General Mills, Inc., a multinational manufacturer and marketer of branded… | SELL | 3,890 | $194.5K | −20.7%hist | −71.1%hist |
| 9/11/2026 | Form 410b5-1 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | Verghese VikramChief Financial OfficerVikram Verghese has served as our Chief Financial Officer since June 2023. He joined the Company in November 2021 as Senior Vice President of Upstream Marketing, Business Development, and Strategy. Prior to that, Mr. Verghese held various positions at Medtronic from 2008 until 2021 in various leadership roles spanning global marketing, regulatory and clinical affairs and business development. After completing his undergraduate degree in Electrical and Electronic Engineering in India, Mr. Verghese received an M.S. in Biomedical Engineering from the University of Southern California and an M.B.A. from University of Pennsylvania’s The Wharton School. He is also a CFA charter holder. Campbell D.K. Rogers, M.D.… | SELL | 29,714 | $1.49M | — | — |
| 9/10/2026 | Form 410b5-1 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | Farquhar John C.M.Chief Executive OfficerJohn C.M. Farquhar has served as our Chief Executive Officer and as a member of our Board since March 2022 and as our President since January 2022, and he served as our Chief Operating Officer from July 2021 to March 2022. Prior to joining the Company, from March 2008 to July 2021, Mr. Farquhar held numerous positions of increasing responsibility across the cardiovascular and diabetes portfolios of Medtronic Public Limited Company (“Medtronic”), a global medical technology company, most recently serving as President and General Manager from June 2018 until July 2021. Prior to that, Mr. Farquhar served as a Marketing Manager at General Mills, Inc., a multinational manufacturer and marketer of branded… | SELL | 35,010 | $1.63M | −20.7%hist | −71.1%hist |
| 9/8/2026 | Form 410b5-1 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | Verghese VikramChief Financial OfficerVikram Verghese has served as our Chief Financial Officer since June 2023. He joined the Company in November 2021 as Senior Vice President of Upstream Marketing, Business Development, and Strategy. Prior to that, Mr. Verghese held various positions at Medtronic from 2008 until 2021 in various leadership roles spanning global marketing, regulatory and clinical affairs and business development. After completing his undergraduate degree in Electrical and Electronic Engineering in India, Mr. Verghese received an M.S. in Biomedical Engineering from the University of Southern California and an M.B.A. from University of Pennsylvania’s The Wharton School. He is also a CFA charter holder. Campbell D.K. Rogers, M.D.… | SELL | 6,640 | $332.2K | — | — |
| 9/3/2026 | Form 410b5-1 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | Verghese VikramChief Financial OfficerVikram Verghese has served as our Chief Financial Officer since June 2023. He joined the Company in November 2021 as Senior Vice President of Upstream Marketing, Business Development, and Strategy. Prior to that, Mr. Verghese held various positions at Medtronic from 2008 until 2021 in various leadership roles spanning global marketing, regulatory and clinical affairs and business development. After completing his undergraduate degree in Electrical and Electronic Engineering in India, Mr. Verghese received an M.S. in Biomedical Engineering from the University of Southern California and an M.B.A. from University of Pennsylvania’s The Wharton School. He is also a CFA charter holder. Campbell D.K. Rogers, M.D.… | SELL | 27,540 | $1.37M | — | — |
| 9/2/2026 | Form 410b5-1 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | Verghese VikramChief Financial OfficerVikram Verghese has served as our Chief Financial Officer since June 2023. He joined the Company in November 2021 as Senior Vice President of Upstream Marketing, Business Development, and Strategy. Prior to that, Mr. Verghese held various positions at Medtronic from 2008 until 2021 in various leadership roles spanning global marketing, regulatory and clinical affairs and business development. After completing his undergraduate degree in Electrical and Electronic Engineering in India, Mr. Verghese received an M.S. in Biomedical Engineering from the University of Southern California and an M.B.A. from University of Pennsylvania’s The Wharton School. He is also a CFA charter holder. Campbell D.K. Rogers, M.D.… | SELL | 5,876 | $297.3K | — | — |
| 8/21/2026 | Form 410b5-1 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | Farquhar John C.M.Chief Executive OfficerJohn C.M. Farquhar has served as our Chief Executive Officer and as a member of our Board since March 2022 and as our President since January 2022, and he served as our Chief Operating Officer from July 2021 to March 2022. Prior to joining the Company, from March 2008 to July 2021, Mr. Farquhar held numerous positions of increasing responsibility across the cardiovascular and diabetes portfolios of Medtronic Public Limited Company (“Medtronic”), a global medical technology company, most recently serving as President and General Manager from June 2018 until July 2021. Prior to that, Mr. Farquhar served as a Marketing Manager at General Mills, Inc., a multinational manufacturer and marketer of branded… | SELL | 27,230 | $1.36M | −20.7%hist | −71.1%hist |
| 8/18/2026 | Form 410b5-1 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | Farquhar John C.M.Chief Executive OfficerJohn C.M. Farquhar has served as our Chief Executive Officer and as a member of our Board since March 2022 and as our President since January 2022, and he served as our Chief Operating Officer from July 2021 to March 2022. Prior to joining the Company, from March 2008 to July 2021, Mr. Farquhar held numerous positions of increasing responsibility across the cardiovascular and diabetes portfolios of Medtronic Public Limited Company (“Medtronic”), a global medical technology company, most recently serving as President and General Manager from June 2018 until July 2021. Prior to that, Mr. Farquhar served as a Marketing Manager at General Mills, Inc., a multinational manufacturer and marketer of branded… | SELL | 32,676 | $1.47M | −20.7%hist | −71.1%hist |
| 8/17/2026 | Form 410b5-1 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | Rogers CampbellChief Medical Officer | SELL | 9,219 | $380.1K | −36.8%hist | −65.3%hist |
| 8/14/2026 | Form 410b5-1 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | Farquhar John C.M.Chief Executive OfficerJohn C.M. Farquhar has served as our Chief Executive Officer and as a member of our Board since March 2022 and as our President since January 2022, and he served as our Chief Operating Officer from July 2021 to March 2022. Prior to joining the Company, from March 2008 to July 2021, Mr. Farquhar held numerous positions of increasing responsibility across the cardiovascular and diabetes portfolios of Medtronic Public Limited Company (“Medtronic”), a global medical technology company, most recently serving as President and General Manager from June 2018 until July 2021. Prior to that, Mr. Farquhar served as a Marketing Manager at General Mills, Inc., a multinational manufacturer and marketer of branded… | SELL | 15,560 | $607.8K | −20.7%hist | −71.1%hist |
| 8/10/2026 | Form 410b5-1 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | Farquhar John C.M.Chief Executive OfficerJohn C.M. Farquhar has served as our Chief Executive Officer and as a member of our Board since March 2022 and as our President since January 2022, and he served as our Chief Operating Officer from July 2021 to March 2022. Prior to joining the Company, from March 2008 to July 2021, Mr. Farquhar held numerous positions of increasing responsibility across the cardiovascular and diabetes portfolios of Medtronic Public Limited Company (“Medtronic”), a global medical technology company, most recently serving as President and General Manager from June 2018 until July 2021. Prior to that, Mr. Farquhar served as a Marketing Manager at General Mills, Inc., a multinational manufacturer and marketer of branded… | SELL | 22,562 | $638.7K | −20.7%hist | −71.1%hist |
| 7/15/2026 | Form 410b5-1 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | Rogers CampbellChief Medical Officer | SELL | 9,219 | $237.1K | −36.8%hist | −65.3%hist |
| 7/10/2026 | Form 410b5-1 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | Farquhar John C.M.Chief Executive OfficerJohn C.M. Farquhar has served as our Chief Executive Officer and as a member of our Board since March 2022 and as our President since January 2022, and he served as our Chief Operating Officer from July 2021 to March 2022. Prior to joining the Company, from March 2008 to July 2021, Mr. Farquhar held numerous positions of increasing responsibility across the cardiovascular and diabetes portfolios of Medtronic Public Limited Company (“Medtronic”), a global medical technology company, most recently serving as President and General Manager from June 2018 until July 2021. Prior to that, Mr. Farquhar served as a Marketing Manager at General Mills, Inc., a multinational manufacturer and marketer of branded… | SELL | 22,562 | $626.1K | −20.7%hist | −71.1%hist |
| 6/24/2026 | Form 410b5-1 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | Farquhar John C.M.Chief Executive OfficerJohn C.M. Farquhar has served as our Chief Executive Officer and as a member of our Board since March 2022 and as our President since January 2022, and he served as our Chief Operating Officer from July 2021 to March 2022. Prior to joining the Company, from March 2008 to July 2021, Mr. Farquhar held numerous positions of increasing responsibility across the cardiovascular and diabetes portfolios of Medtronic Public Limited Company (“Medtronic”), a global medical technology company, most recently serving as President and General Manager from June 2018 until July 2021. Prior to that, Mr. Farquhar served as a Marketing Manager at General Mills, Inc., a multinational manufacturer and marketer of branded… | SELL | 38,900 | $1.36M | −20.7%hist | −71.1%hist |
| 6/10/2026 | Form 410b5-1 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | Farquhar John C.M.Chief Executive OfficerJohn C.M. Farquhar has served as our Chief Executive Officer and as a member of our Board since March 2022 and as our President since January 2022, and he served as our Chief Operating Officer from July 2021 to March 2022. Prior to joining the Company, from March 2008 to July 2021, Mr. Farquhar held numerous positions of increasing responsibility across the cardiovascular and diabetes portfolios of Medtronic Public Limited Company (“Medtronic”), a global medical technology company, most recently serving as President and General Manager from June 2018 until July 2021. Prior to that, Mr. Farquhar served as a Marketing Manager at General Mills, Inc., a multinational manufacturer and marketer of branded… | SELL | 22,562 | $643.0K | −62.2% | −71.1%hist |
| 5/18/2026 | Form 410b5-1 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | Rogers CampbellChief Medical Officer | SELL | 9,219 | $261.3K | −63.5% | −65.3%hist |
| 5/11/2026 | Form 410b5-1 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | Farquhar John C.M.Chief Executive OfficerJohn C.M. Farquhar has served as our Chief Executive Officer and as a member of our Board since March 2022 and as our President since January 2022, and he served as our Chief Operating Officer from July 2021 to March 2022. Prior to joining the Company, from March 2008 to July 2021, Mr. Farquhar held numerous positions of increasing responsibility across the cardiovascular and diabetes portfolios of Medtronic Public Limited Company (“Medtronic”), a global medical technology company, most recently serving as President and General Manager from June 2018 until July 2021. Prior to that, Mr. Farquhar served as a Marketing Manager at General Mills, Inc., a multinational manufacturer and marketer of branded… | SELL | 22,562 | $657.0K | +0.14% | −71.1%hist |
| 4/30/2026 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | BCLS Fund III Investments GP, LLC · BCLS Fund III Investments, LP · Bain Capital Life Sciences Fund III, L.P. · Bain Capital Life Sciences III General Partner, LLC · Bain Capital Life Sciences Investors, LLC10% owner | SELL | 892,533 | $26.04M | +15.9% | −32.0%hist | |
| 4/30/2026 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | BCLS Fund III Investments GP, LLC · BCLS Fund III Investments, LP · Bain Capital Life Sciences Fund III, L.P. · Bain Capital Life Sciences III General Partner, LLC · Bain Capital Life Sciences Investors, LLC10% owner | SELL | 56,224 | $1.69M | +15.9% | −32.0%hist | |
| 4/29/2026 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | BCLS Fund III Investments GP, LLC · BCLS Fund III Investments, LP · Bain Capital Life Sciences Fund III, L.P. · Bain Capital Life Sciences III General Partner, LLC · Bain Capital Life Sciences Investors, LLC10% owner | SELL | 797,133 | $23.41M | +13.3% | −32.0%hist | |
| 4/28/2026 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | BCLS Fund III Investments GP, LLC · BCLS Fund III Investments, LP · Bain Capital Life Sciences Fund III, L.P. · Bain Capital Life Sciences III General Partner, LLC · Bain Capital Life Sciences Investors, LLC10% owner | SELL | 254,110 | $7.75M | +17.0% | −32.0%hist | |
| 4/10/2026 | Form 410b5-1 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | Farquhar John C.M.Chief Executive OfficerJohn C.M. Farquhar has served as our Chief Executive Officer and as a member of our Board since March 2022 and as our President since January 2022, and he served as our Chief Operating Officer from July 2021 to March 2022. Prior to joining the Company, from March 2008 to July 2021, Mr. Farquhar held numerous positions of increasing responsibility across the cardiovascular and diabetes portfolios of Medtronic Public Limited Company (“Medtronic”), a global medical technology company, most recently serving as President and General Manager from June 2018 until July 2021. Prior to that, Mr. Farquhar served as a Marketing Manager at General Mills, Inc., a multinational manufacturer and marketer of branded… | SELL | 22,562 | $602.9K | −2.86% | −71.1%hist |
| 4/1/2026 | Form 410b5-1 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | Rogers CampbellChief Medical Officer | SELL | 64,533 | $1.59M | −19.8% | −65.3%hist |
| 3/19/2026 | Form 410b5-1 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | Rogers CampbellChief Medical Officer | SELL | 64,533 | $1.66M | −26.8% | −86.7% |
| 3/18/2026 | Form 410b5-1 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | Farquhar John C.M.Chief Executive OfficerJohn C.M. Farquhar has served as our Chief Executive Officer and as a member of our Board since March 2022 and as our President since January 2022, and he served as our Chief Operating Officer from July 2021 to March 2022. Prior to joining the Company, from March 2008 to July 2021, Mr. Farquhar held numerous positions of increasing responsibility across the cardiovascular and diabetes portfolios of Medtronic Public Limited Company (“Medtronic”), a global medical technology company, most recently serving as President and General Manager from June 2018 until July 2021. Prior to that, Mr. Farquhar served as a Marketing Manager at General Mills, Inc., a multinational manufacturer and marketer of branded… | SELL | 9,725 | $243.1K | −25.8% | −94.5% |
| 3/10/2026 | Form 410b5-1 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | Farquhar John C.M.Chief Executive OfficerJohn C.M. Farquhar has served as our Chief Executive Officer and as a member of our Board since March 2022 and as our President since January 2022, and he served as our Chief Operating Officer from July 2021 to March 2022. Prior to joining the Company, from March 2008 to July 2021, Mr. Farquhar held numerous positions of increasing responsibility across the cardiovascular and diabetes portfolios of Medtronic Public Limited Company (“Medtronic”), a global medical technology company, most recently serving as President and General Manager from June 2018 until July 2021. Prior to that, Mr. Farquhar served as a Marketing Manager at General Mills, Inc., a multinational manufacturer and marketer of branded… | SELL | 12,837 | $290.9K | −25.9% | −111.4% |
| 3/5/2026 | Form 410b5-1 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | Cullivan Julie ADirector | SELL | 9,122 | $228.1K | −16.0% | −102.9% |
| 2/12/2026 | Form 410b5-1 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | Rogers CampbellChief Medical Officer | SELL | 65,153 | $1.60M | −38.7% | −31.3% |
| 2/10/2026 | Form 410b5-1 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | Farquhar John C.M.Chief Executive OfficerJohn C.M. Farquhar has served as our Chief Executive Officer and as a member of our Board since March 2022 and as our President since January 2022, and he served as our Chief Operating Officer from July 2021 to March 2022. Prior to joining the Company, from March 2008 to July 2021, Mr. Farquhar held numerous positions of increasing responsibility across the cardiovascular and diabetes portfolios of Medtronic Public Limited Company (“Medtronic”), a global medical technology company, most recently serving as President and General Manager from June 2018 until July 2021. Prior to that, Mr. Farquhar served as a Marketing Manager at General Mills, Inc., a multinational manufacturer and marketer of branded… | SELL | 22,562 | $619.6K | −7.66% | −7.51% |
| 2/5/2026 | Form 410b5-1 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | Cullivan Julie ADirector | SELL | 8,000 | $218.6K | −16.5% | −4.96% |
| 2/4/2026 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | BCLS Fund III Investments GP, LLC · BCLS Fund III Investments, LP · Bain Capital Life Sciences Fund III, L.P. · Bain Capital Life Sciences III General Partner, LLC · Bain Capital Life Sciences Investors, LLC10% owner | SELL | 2,000,000 | $56.10M | −6.47% | +4.90% | |
| 12/16/2025 | HTFLHeartflow, Inc Heartflow, Inc · Surgical & Medical Instruments & ApparatusIndustrySurgical & Medical Instruments & ApparatusMkt cap (est.)$21.04BPrice$50.7552w high$50.7552w low$20.49 | Lightcap Jeffrey CDirector | BUY | 40,000 | $1.05M | −20.7% | +24.0% |
Chart shows split-adjusted close for the last three years, or the selected date range. Triangles mark open-market Form 4 purchases and sales in that window.